Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK)
Makes and distributes medicines and healthcare products across China.
11.95+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-4.4%
The outlook
Shanghai Pharmaceuticals is trading at 11.95 with analyst consensus leaning toward Buy, supported by a 17% gap between current price and average price targets. The stock sits above both its 50- and 200-day moving averages and roughly midway through its 52-week range, suggesting stable intermediate momentum. At a trailing P/E of 6.6, valuations appear modest relative to analyst sentiment.
What’s behind the score
Analyst consensusBuy — 1.9 avg of 9 analysts
Price trendAbove its 50- & 200-day averages
52-week range46% of the way from its 52-week low to high
Price targetAvg target +17% vs current price
Analyst price target
~12-month · 9 analysts14.04average target+17.5% vs now
Now 11.95
Low 10.63High 16.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$44.31B
52-wk high
13.12
52-wk low
10.96
50-day avg
11.77
200-day avg
11.82
Trailing P/E
6.6